长轴视野(LAFOV)PET/CT 在前列腺癌中的应用
本文综述长轴视野(LAFOV)PET/CT 在前列腺癌 PSMA 配体显像中的应用。早期临床结果显示,相较标准轴视野系统,LAFOV 系统在灵敏度、图像质量和病灶定量方面均有显著提升,并可实现全身动态 PET 显像。初步文献表明其检出前列腺癌病灶灵敏度高,且可实现超快或超低剂量检查。
要点
- LAFOV PET/CT 较标准轴视野系统在灵敏度、图像质量和病灶定量方面有显著提升。
- 早期文献显示 LAFOV PSMA PET/CT 检出前列腺癌病灶灵敏度高,并可实现超快或超低剂量检查。
- 全身动态 PET 首次使以高时间分辨率捕捉 PSMA 配体在所有主要器官和多数肿瘤病灶中的药代动力学成为可能。
核心结论
- 新 LAFOV 扫描仪可能进一步增强 PSMA 配体 PET/CT 在前列腺癌诊断与管理中的应用和潜力。
- 初步但持续增长的文献已显示 LAFOV PSMA PET/CT 检出前列腺癌病灶灵敏度高,并提供超快或超低剂量检查的可能性。
研究设计与样本
- 本文为综述,汇总 LAFOV PET/CT 在前列腺癌 PSMA 配体显像中应用的初步研究主要结果。
主要发现
- 早期临床应用结果显示,LAFOV 系统较既往标准轴视野系统在灵敏度、图像质量和病灶定量方面有显著改善,并支持全身动态 PET 显像。
- 初步文献显示 LAFOV PSMA PET/CT 检出前列腺癌病灶灵敏度高,同时提供超快或超低剂量检查的可能。
- 全身动态 PET 首次使以高时间分辨率捕捉 PSMA 配体在所有主要器官和多数肿瘤病灶中的药代动力学成为可能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PSMA-targeted PET/CT is currently considered the most effective non-invasive diagnostic technique for imaging PSMA-positive lesions in prostate cancer (PC), and its introduction has significantly enhanced the role of nuclear medicine in both the diagnosis and therapy (theranostics) of this oncological entity. In line with developments in radiopharmaceuticals, significant progress has been made in the development of PET/CT systems. In particular, the advent of long axial field-of-view (LAFOV) PET/CT scanners has represented a major leap forward in molecular imaging, with early results from clinical applications of these systems showing significant improvements over previous standard axial field-of-view systems in terms of sensitivity, image quality and lesion quantification, while enabling whole-body dynamic PET imaging. In this context, the introduction of the new LAFOV scanners may further enhance the use and potential of PSMA-ligand PET/CT in the diagnosis and management of PC. The initial but steadily growing literature on the application of the new technology in the field of PSMA-ligand PET/CT has already yielded encouraging results regarding the detection of PC lesions with high sensitivity while providing the possibility of ultra-fast or ultra-low dose examinations. Moreover, whole-body dynamic PET has rendered for the first time feasible to capture the pharmacokinetics PSMA-ligands in all major organs and most tumor lesions with high temporal resolution. The main results of these studies are presented in this review.
引用
- Sachpekidis C, Dimitrakopoulou-Strauss A. Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer. Semin Nucl Med. 2024. PMID: 38825439. doi:10.1053/j.semnuclmed.2024.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。